Offering Sorafenat :
Sorafenat contains sorafenib, which is a small molecular inhibitor of several tyrosine protein kinases.
Manufactured By: Natco Pharma Ltd.
Indication: Sorafenat is used for the treatment of primary kidney cancer (advanced renal cell carcinoma) and advanced primary liver cancer.
Available As : 200 mg tablets.Bottle of 120 tablets.
Note : Sorafenat is a prescription drug and should be used under proper medical guidance and advice